Literature DB >> 25036948

A single amino acid polymorphism in the Drosophila melanogaster Dα1 (ALS) subunit enhances neonicotinoid efficacy at Dα1-chicken β2 hybrid nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes.

Makoto Ihara1, Naoya Shimazu, Mai Utsunomiya, Miki Akamatsu, David B Sattelle, Kazuhiko Matsuda.   

Abstract

Polymorphisms are sometimes observed in native insect nicotinic acetylcholine receptor (nAChR) subunits, which are important insecticide targets, yet little is known of their impact on insecticide actions. Here we investigated the effects of a polymorphism involving the substitution of histidine108 by leucine in the Drosophila melanogaster Dα1 subunit on the agonist actions of the neurotransmitter acetylcholine (ACh) and two commercial neonicotinoid insecticides (imidacloprid and clothianidin). There was no significant impact of the H108L substitution on either the ACh EC50, the concentration leading to a half maximal ACh response, or the maximum current amplitude in response at 10 μM ACh, of the Dα1-chicken β2 nAChR expressed in Xenopus laevis oocytes. However, the response amplitudes to imidacloprid and clothianidin were significantly enhanced, indicating a role of His108 in the selective interactions of Dα1 with these neonicotinoids.

Entities:  

Keywords:  Dα1 subunit; clothianidin; imidacloprid; ion channel; nicotinic acetylcholine receptor

Mesh:

Substances:

Year:  2014        PMID: 25036948     DOI: 10.1080/09168451.2014.891928

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  1 in total

1.  Loops D, E and G in the Drosophila Dα1 subunit contribute to high neonicotinoid sensitivity of Dα1-chicken β2 nicotinic acetylcholine receptor.

Authors:  Makoto Ihara; Mai Hikida; Hiroyuki Matsushita; Kyosuke Yamanaka; Yuya Kishimoto; Kazuki Kubo; Shun Watanabe; Mifumi Sakamoto; Koutaro Matsui; Akihiro Yamaguchi; Daiki Okuhara; Shogo Furutani; David B Sattelle; Kazuhiko Matsuda
Journal:  Br J Pharmacol       Date:  2017-08-24       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.